Literature DB >> 4006933

Ceftriaxone: a three centre comparative in vitro susceptibility study.

A M Emmerson, P A Lamport, D S Reeves, M J Bywater, H A Holt, R Wise, J Andrews, M J Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4006933     DOI： 10.1007/bf02013584

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin.

Authors:  A M Harris; S J Plested; P B Harper
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

2.  Interpretation of susceptibility testing of ceftriaxone.

Authors:  E Squires; R Cleeland; J Christenson; E Boehni
Journal:  Am J Med       Date:  1984-10-19       Impact factor: 4.965

3.  Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.

Authors:  P J McNamara; K Stoeckel; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Comparative activity in vitro of piperacillin.

Authors:  D S Reeves; H A Holt; M J Bywater; J L Bidwell
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

5.  Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.

Authors:  H Grimm
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

Review 6.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

7.  An evaluation of recently developed antibiotics.

Authors:  C J Fernandes; D A Stevens; S I Murray; V P Ackerman
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.